LAGHENO

Serial Number 97430578
733

Registration Progress

Application Filed
May 26, 2022
Under Examination
Jun 13, 2023
Approved for Publication
Apr 18, 2023
Published for Opposition
Apr 18, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Dec 13, 2025 37 days

Trademark Image

LAGHENO

Basic Information

Serial Number
97430578
Filing Date
May 26, 2022
Published for Opposition
April 18, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Apr 24, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 100012192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Andrea Christensen

USPTO Deadlines

Next Deadline
37 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
December 13, 2025
Extension Available
Until June 13, 2024

Application History

31 events
Date Code Type Description Documents
Oct 30, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 25, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 24, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 24, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 31, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 31, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 31, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 31, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 25, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 26, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 6, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 6, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 6, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 6, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 6, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 6, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 29, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 15, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 14, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 30, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification

International Classes
005